Mucolipidosis II presenting as severe neonatal hyperparathyroidism

Sheila Unger, David A. Paul, Michelle C. Nino, Charles P. McKay, Stephen Miller, Etienne Sochett, Nancy Braverman, Joe T.R. Clarke, David E.C. Cole, Andrea Superti-Furga

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Mucolipidosis II (ML II or I-cell disease ) (OMIM 252500) is an autosomal recessive lysosomal enzyme targeting disorder that usually presents between 6 and 12 months of age with a clinical phenotype resembling Hurler syndrome and a radiological picture of dysostosis multiplex. When ML II is severe enough to be detected in the newborn period, the radiological changes have been described as similar to hyperparathyroidism or rickets. The biological basis of these findings has not been explored and few biochemical measurements have been recorded. We describe three unrelated infants with ML II who had radiological features of intrauterine hyperparathyroidism and biochemical findings consistent with severe secondary neonatal hyperparathyroidism (marked elevation of serum parathyroid hormone and alkaline phosphatase levels). The vitamin D metabolites were not substantially different from normal and repeatedly normal calcium concentrations excluded vitamin D deficiency rickets and neonatal severe hyperparathyroidism secondary to calcium-sensing receptor gene mutations (OMIM 239200). The pathogenesis of severe hyperparathyroidism in the fetus and newborn with ML II is unexplained. We hypothesize that the enzyme targeting defect of ML II interferes with transplacental calcium transport leading to a calcium starved fetus and activation of the parathyroid response to maintain extracellular calcium concentrations within the normal range. Conclusion: Newborns with mucolipidosis II can present with radiological and biochemical signs of hyperparathyroidism. Awareness of this phenomenon may help in avoiding diagnostic pitfalls and establishing a proper diagnosis and therapy.

Original languageEnglish (US)
Pages (from-to)236-243
Number of pages8
JournalEuropean Journal of Pediatrics
Volume164
Issue number4
DOIs
StatePublished - Apr 1 2005

Fingerprint

Mucolipidoses
Hyperparathyroidism
Calcium
Genetic Databases
Rickets
Secondary Hyperparathyroidism
Newborn Infant
Fetus
Dysostoses
Mucopolysaccharidosis I
Lysosomal Storage Diseases
Calcium-Sensing Receptors
Vitamin D Deficiency
Parathyroid Hormone
Vitamin D
Alkaline Phosphatase
Reference Values
mutalipocin II
Phenotype
Mutation

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Unger, S., Paul, D. A., Nino, M. C., McKay, C. P., Miller, S., Sochett, E., ... Superti-Furga, A. (2005). Mucolipidosis II presenting as severe neonatal hyperparathyroidism. European Journal of Pediatrics, 164(4), 236-243. https://doi.org/10.1007/s00431-004-1591-x

Mucolipidosis II presenting as severe neonatal hyperparathyroidism. / Unger, Sheila; Paul, David A.; Nino, Michelle C.; McKay, Charles P.; Miller, Stephen; Sochett, Etienne; Braverman, Nancy; Clarke, Joe T.R.; Cole, David E.C.; Superti-Furga, Andrea.

In: European Journal of Pediatrics, Vol. 164, No. 4, 01.04.2005, p. 236-243.

Research output: Contribution to journalArticle

Unger, S, Paul, DA, Nino, MC, McKay, CP, Miller, S, Sochett, E, Braverman, N, Clarke, JTR, Cole, DEC & Superti-Furga, A 2005, 'Mucolipidosis II presenting as severe neonatal hyperparathyroidism', European Journal of Pediatrics, vol. 164, no. 4, pp. 236-243. https://doi.org/10.1007/s00431-004-1591-x
Unger, Sheila ; Paul, David A. ; Nino, Michelle C. ; McKay, Charles P. ; Miller, Stephen ; Sochett, Etienne ; Braverman, Nancy ; Clarke, Joe T.R. ; Cole, David E.C. ; Superti-Furga, Andrea. / Mucolipidosis II presenting as severe neonatal hyperparathyroidism. In: European Journal of Pediatrics. 2005 ; Vol. 164, No. 4. pp. 236-243.
@article{82a7facbbad24f3e895670089622444d,
title = "Mucolipidosis II presenting as severe neonatal hyperparathyroidism",
abstract = "Mucolipidosis II (ML II or I-cell disease ) (OMIM 252500) is an autosomal recessive lysosomal enzyme targeting disorder that usually presents between 6 and 12 months of age with a clinical phenotype resembling Hurler syndrome and a radiological picture of dysostosis multiplex. When ML II is severe enough to be detected in the newborn period, the radiological changes have been described as similar to hyperparathyroidism or rickets. The biological basis of these findings has not been explored and few biochemical measurements have been recorded. We describe three unrelated infants with ML II who had radiological features of intrauterine hyperparathyroidism and biochemical findings consistent with severe secondary neonatal hyperparathyroidism (marked elevation of serum parathyroid hormone and alkaline phosphatase levels). The vitamin D metabolites were not substantially different from normal and repeatedly normal calcium concentrations excluded vitamin D deficiency rickets and neonatal severe hyperparathyroidism secondary to calcium-sensing receptor gene mutations (OMIM 239200). The pathogenesis of severe hyperparathyroidism in the fetus and newborn with ML II is unexplained. We hypothesize that the enzyme targeting defect of ML II interferes with transplacental calcium transport leading to a calcium starved fetus and activation of the parathyroid response to maintain extracellular calcium concentrations within the normal range. Conclusion: Newborns with mucolipidosis II can present with radiological and biochemical signs of hyperparathyroidism. Awareness of this phenomenon may help in avoiding diagnostic pitfalls and establishing a proper diagnosis and therapy.",
author = "Sheila Unger and Paul, {David A.} and Nino, {Michelle C.} and McKay, {Charles P.} and Stephen Miller and Etienne Sochett and Nancy Braverman and Clarke, {Joe T.R.} and Cole, {David E.C.} and Andrea Superti-Furga",
year = "2005",
month = "4",
day = "1",
doi = "10.1007/s00431-004-1591-x",
language = "English (US)",
volume = "164",
pages = "236--243",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Mucolipidosis II presenting as severe neonatal hyperparathyroidism

AU - Unger, Sheila

AU - Paul, David A.

AU - Nino, Michelle C.

AU - McKay, Charles P.

AU - Miller, Stephen

AU - Sochett, Etienne

AU - Braverman, Nancy

AU - Clarke, Joe T.R.

AU - Cole, David E.C.

AU - Superti-Furga, Andrea

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Mucolipidosis II (ML II or I-cell disease ) (OMIM 252500) is an autosomal recessive lysosomal enzyme targeting disorder that usually presents between 6 and 12 months of age with a clinical phenotype resembling Hurler syndrome and a radiological picture of dysostosis multiplex. When ML II is severe enough to be detected in the newborn period, the radiological changes have been described as similar to hyperparathyroidism or rickets. The biological basis of these findings has not been explored and few biochemical measurements have been recorded. We describe three unrelated infants with ML II who had radiological features of intrauterine hyperparathyroidism and biochemical findings consistent with severe secondary neonatal hyperparathyroidism (marked elevation of serum parathyroid hormone and alkaline phosphatase levels). The vitamin D metabolites were not substantially different from normal and repeatedly normal calcium concentrations excluded vitamin D deficiency rickets and neonatal severe hyperparathyroidism secondary to calcium-sensing receptor gene mutations (OMIM 239200). The pathogenesis of severe hyperparathyroidism in the fetus and newborn with ML II is unexplained. We hypothesize that the enzyme targeting defect of ML II interferes with transplacental calcium transport leading to a calcium starved fetus and activation of the parathyroid response to maintain extracellular calcium concentrations within the normal range. Conclusion: Newborns with mucolipidosis II can present with radiological and biochemical signs of hyperparathyroidism. Awareness of this phenomenon may help in avoiding diagnostic pitfalls and establishing a proper diagnosis and therapy.

AB - Mucolipidosis II (ML II or I-cell disease ) (OMIM 252500) is an autosomal recessive lysosomal enzyme targeting disorder that usually presents between 6 and 12 months of age with a clinical phenotype resembling Hurler syndrome and a radiological picture of dysostosis multiplex. When ML II is severe enough to be detected in the newborn period, the radiological changes have been described as similar to hyperparathyroidism or rickets. The biological basis of these findings has not been explored and few biochemical measurements have been recorded. We describe three unrelated infants with ML II who had radiological features of intrauterine hyperparathyroidism and biochemical findings consistent with severe secondary neonatal hyperparathyroidism (marked elevation of serum parathyroid hormone and alkaline phosphatase levels). The vitamin D metabolites were not substantially different from normal and repeatedly normal calcium concentrations excluded vitamin D deficiency rickets and neonatal severe hyperparathyroidism secondary to calcium-sensing receptor gene mutations (OMIM 239200). The pathogenesis of severe hyperparathyroidism in the fetus and newborn with ML II is unexplained. We hypothesize that the enzyme targeting defect of ML II interferes with transplacental calcium transport leading to a calcium starved fetus and activation of the parathyroid response to maintain extracellular calcium concentrations within the normal range. Conclusion: Newborns with mucolipidosis II can present with radiological and biochemical signs of hyperparathyroidism. Awareness of this phenomenon may help in avoiding diagnostic pitfalls and establishing a proper diagnosis and therapy.

UR - http://www.scopus.com/inward/record.url?scp=20244374546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20244374546&partnerID=8YFLogxK

U2 - 10.1007/s00431-004-1591-x

DO - 10.1007/s00431-004-1591-x

M3 - Article

VL - 164

SP - 236

EP - 243

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 4

ER -